Sponsor intelligence · OTHER
Clinical trials sponsored by
Tianjin Medical University Cancer Institute And Hospital.
Real, source-linked trial activity for Tianjin Medical University Cancer Institute And Hospital: 12 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Aug 5, 2026. Source-linked, daily-refreshed.
PHASE2 8NA 3N/A 1
Newest Tianjin Medical University Cancer Institute And Hospital trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 7d ago | To Explore a Single-arm Phase II Study on Intestinal Microbiota Transp | NA | NOT_YET_RECRUITING | ↗ |
| 7d ago | Study on the Combined Treatment of Hepatocellular Carcinoma With Envaf | NA | NOT_YET_RECRUITING | ↗ |
| 8d ago | Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In U | Ph 2 | RECRUITING | ↗ |
| 13d ago | Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for | Ph 2 | RECRUITING | ↗ |
| 14d ago | Butyrate Yogurt for Cancer Constipation | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 15d ago | Early Response-guided Sequential Radiotherapy After Chemoimmunotherapy | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 29d ago | Sac-TMT Combined With Fruquintinib as Second-Line Treatment in Patient | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 30d ago | Becotatug Vedotin Plus Tislelizumab and Low-Dose Lenvatinib for Advanc | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 35d ago | Risk Stratification and Proactive Nursing Intervention for Acute Kidne | NA | NOT_YET_RECRUITING | ↗ |
| 41d ago | The Efficacy of Combined Peripheral Blood CTCs and Serum HER2 Detectio | N/A | NOT_YET_RECRUITING | ↗ |
| 49d ago | Eparlitozoviril as Adjuvant Therapy for Resectable HCC With MVI | Ph 2 | ACTIVE_NOT_RECRUITING | ↗ |
| 50d ago | Sintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therap | Ph 2 | ACTIVE_NOT_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Tianjin Medical University Cancer Institute And Hospital (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.